4.8 Review

Cataracts

期刊

LANCET
卷 390, 期 10094, 页码 600-612

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)30544-5

关键词

-

资金

  1. Microsurgical Technology
  2. NovaMedica
  3. Minosys
  4. ValeantBausch Lomb
  5. Morcher
  6. Santen
  7. Bayer Alcon
  8. Carl Zeiss Meditec
  9. Novartis

向作者/读者索取更多资源

An estimated 95 million people worldwide are affected by cataract. Cataract still remains the leading cause of blindness in middle-income and low-income countries. With the advancement of surgical technology and techniques, cataract surgery has evolved to small-incisional surgery with rapid visual recovery, good visual outcomes, and minimal complications in most patients. With the development of advanced technology in intraocular lenses, the combined treatment of cataract and astigmatism or presbyopia, or both, is possible. Paediatric cataracts have a different pathogenesis, surgical concerns, and postoperative clinical course from those of age-related cataracts, and the visual outcome is multifactorial and dependent on postoperative visual rehabilitation. New developments in cataract surgery will continue to improve the visual, anatomical, and patient-reported outcomes. Future work should focus on promoting the accessibility and quality of cataract surgery in developing countries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据